Epigenetic regulation of Toll-like receptors 2 and 4 in kidney disease
Author:
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Drug Discovery,Molecular Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00109-022-02218-y.pdf
Reference68 articles.
1. Coresh J (2017) Update on the burden of CKD. J Am Soc Nephrol 28(4):1020–1022
2. Romagnani P et al (2017) Chronic kidney disease. Nat Rev Dis Primers 3(1):17088
3. Muskiet MHA, Wheeler DC, Heerspink HJL (2019) New pharmacological strategies for protecting kidney function in type 2 diabetes. Lancet Diabetes Endocrinol 7(5):397–412
4. Majumder S et al (2022) Toll-like receptor 4 mutation protects the kidney from Ang-II-induced hypertensive injury. Pharmacol Res 175:106030
5. Mudaliar H et al (2013) The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules. Am J Physiol Renal Physiol 305(2):F143–F154
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Emodin inhibits M1 macrophage activation that related to acute and chronic kidney injury through EGFR/MAPK pathway;Functional & Integrative Genomics;2024-07-30
2. Multiomics integration reveals NETosis heterogeneity and TLR2 as a prognostic biomarker in pancreatic cancer;npj Precision Oncology;2024-05-20
3. Network pharmacology combined with molecular docking and dynamics to assess the synergism of esculetin and phloretin against acute kidney injury-diabetes comorbidity;Molecular Diversity;2024-04-05
4. DDX5 inhibits inflammation by modulating m6A levels of TLR2/4 transcripts during bacterial infection;EMBO Reports;2024-01-05
5. Phloretin as an add-on therapy to losartan attenuates diabetes-induced AKI in rats: A potential therapeutic approach targeting TLR4-induced inflammation;Life Sciences;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3